Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.71 +0.02 (+2.24%)
As of: Oct 22, 2026 · 10:53 AM EDT

Milestone Pharmaceuticals (MIST) EBITDA Margin (2021 - 2022)

Updated

Milestone Pharmaceuticals (MIST) reported EBITDA Margin of -1000.20% for Q3 2022.

Analysis

Milestone Pharmaceuticals (MIST) EBITDA Margin (2021 - 2022) Analysis & Trends

Over the twelve months ended Sep 30, 2022, Milestone Pharmaceuticals' EBITDA Margin came in at -381.39%; for FY2021, it came in at -286.53%.

  • The Q3 2022 figure ranks as the highest quarterly EBITDA Margin since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 35.95%
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn 49.01%
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn 6.02%
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn -
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn 33.11%
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn -124.26%
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn 39.16%
10 Milestone Pharmaceuticals 98.60 Mn -72.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -1,000.20%
Jun 30, 2022 -10,621.52%
Jun 30, 2021 4.90%
API Access

Milestone Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MIST&period=max&api_key=YOUR_API_KEY